2 results match your criteria: "Brigham and Women's Hospital and Children's Hospital Boston and Harvard Medical School[Affiliation]"

Current immunosuppressive regimens suppress alloimmunity by nonspecifically targeting T-cell proliferation, differentiation, and activation. In doing so, they have been effective in dramatically reducing rates of acute rejection and improving short-term allograft survival. However, this is often at the expense of overimmunosuppression.

View Article and Find Full Text PDF